Page 13 - Nasdaq Vktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq vktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Vktx Today - Breaking & Trending Today

Viking Therapeutics (VKTX) Set to Announce Quarterly Earnings on Wednesday

Viking Therapeutics (NASDAQ:VKTX – Get Rating) is scheduled to announce its earnings results after the market closes on Wednesday, April 26th. Analysts expect the company to announce earnings of ($0.24) per share for the quarter. Viking Therapeutics (NASDAQ:VKTX – Get Rating) last posted its quarterly earnings results on Wednesday, February 8th. The biotechnology company reported […] ....

United States , San Diego , Greg Zante , Michaela Dinerman , Lawson Macartney , Stifel Nicolaus , Roth Mkm , Jpmorgan Chase Co , York Mellon Corp , Blackrock Inc , Dimensional Fund Advisors , Therapeutics Inc , Swiss National Bank , Viking Therapeutics , Get Rating , Therapeutics Stock Down , Director Lawson Macartney , National Bank , New York Mellon Corp , Fund Advisors , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) COO Marianna Mancini Sells 12,500 Shares

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) COO Marianna Mancini sold 12,500 shares of the stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $20.00, for a total value of $250,000.00. Following the transaction, the chief operating officer now owns 287,763 shares in the company, […] ....

San Diego , United States , Marianna Mancini , Stifel Nicolaus , Michaela Dinerman , Raymond James , Roth Mkm , Therapeutics Inc , Therapeutics Company Profile , Blackrock Inc , Balyasny Asset Management , Dimensional Fund Advisors , Vanguard Group Inc , Securities Exchange Commission , Boxer Capital , Viking Therapeutics , Get Rating , Exchange Commission , Asset Management , Fund Advisors , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Insider Trading , Nsider Trades ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Greg Zante Sells 7,500 Shares of Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 7,500 shares of the company’s stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $20.00, for a total value of $150,000.00. Following the sale, the chief financial officer now owns 149,279 shares in the company, valued […] ....

San Diego , United States , Michaela Dinerman , Roth Mkm , Greg Zante , Stifel Nicolaus , Brinker Capital Investments , Sg Americas Securities , Steward Partners Investment Advisory , Therapeutics Company Profile , Maxim Group , Therapeutics Inc , Herr Investment Group , Viking Therapeutics , Get Rating , Capital Investments , Investment Group , Partners Investment Advisory , Centiva Capital , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Insider Trading , Nsider Trades ,

Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CEO Sells 79,336 Shares of Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CEO Brian Lian sold 79,336 shares of the firm’s stock in a transaction on Thursday, April 13th. The shares were sold at an average price of $18.45, for a total value of $1,463,749.20. Following the sale, the chief executive officer now directly owns 2,307,963 shares of the company’s […] ....

San Diego , United States , Stifel Nicolaus , Michaela Dinerman , Therapeutics Company Profile , Virtu Financial , Asset Management Corp , Therapeutics Inc , Cetera Advisor Networks , Viking Therapeutics , Get Rating , Brian Lian , Advisor Networks , Gate Manager , Management Corp , Viking Therapeutics Daily , Nasdaq Vktx , Insider Trading , Nsider Trades ,

Greg Zante Sells 56,295 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 56,295 shares of the stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $18.00, for a total transaction of $1,013,310.00. Following the completion of the sale, the chief financial officer now directly owns 149,279 shares of […] ....

San Diego , United States , Greg Zante , Raymond James , Michaela Dinerman , Stifel Nicolaus , Roth Mkm , Steward Partners Investment Advisory , Schonfeld Strategic Advisors , Therapeutics Company Profile , Therapeutics Inc , Morgan Stanley , Securities Exchange Commission , Chartwell Investment Partners , Summit Financial Wealth Advisors , Viking Therapeutics , Get Rating , Exchange Commission , Financial Wealth Advisors , Investment Partners , Partners Investment Advisory , Strategic Advisors , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Insider Trading ,